Literature DB >> 21252952

In vitro antibiotic susceptibility patterns of bacterial keratitis isolates in Oxford, UK: a 10-year review.

H O Orlans1, S J Hornby, I C J W Bowler.   

Abstract

PURPOSE: To analyse the spectrum of bacterial keratitis isolates and their in vitro antibiotic susceptibilities over a 10-year period in Oxford, UK; and to compare the in vitro efficacy of ciprofloxacin with that of the combination of gentamicin and cefuroxime over the same period.
METHODS: All culture-positive corneal scrapes received from the Oxford Eye Hospital between July 1999 and June 2009 were identified retrospectively using a local microbiology database. For analysis of trends over time, the data was split into two equal 5-year periods. Statistical analysis was done using the χ² and Fisher exact tests.
RESULTS: Over the 10-year study period, 467 corneal scrapes were performed of which 252 (54.0%) had positive bacterial cultures, growing a total of 267 organisms. The most commonly isolated bacteria were Staphylococci(40.1%) followed by Pseudomonasspecies (28.5%), other Gram-negative species (17.2%), Streptococci(7.1%), and Corynebacteria(6.0%). Between the first and second time periods there was an increase in the number of coagulase-negative Staphylococciand an increased resistance of the non-Pseudomonas Gram-negative group to chloramphenicol. Of the 189 isolates tested for sensitivity to both empirical antibiotic regimens, 176 (93.2%) were susceptible to ciprofloxacin whereas 188 (99.5%) were susceptible to either gentamicin or cefuroxime (P=0.0015).
CONCLUSIONS: The spectrum of bacterial keratitis isolates and their in vitro antibiotic sensitivity patterns have generally remained stable over time. The combination of gentamicin and cefuroxime provides a broader spectrum of antimicrobial cover than ciprofloxacin monotherapy in Oxford, although both regimens continue to be appropriate choices for the initial management of this condition.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21252952      PMCID: PMC3171240          DOI: 10.1038/eye.2010.231

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  15 in total

1.  In vitro antibiotic resistance in bacterial keratitis in London.

Authors:  S J Tuft; M Matheson
Journal:  Br J Ophthalmol       Date:  2000-07       Impact factor: 4.638

2.  Ulcerative keratitis associated with contact lens wear.

Authors:  E Alfonso; S Mandelbaum; M J Fox; R K Forster
Journal:  Am J Ophthalmol       Date:  1986-04-15       Impact factor: 5.258

3.  Antimicrobial-susceptibility testing of rapidly growing pathogenic bacteria. II. A field trial of four disc-diffusion methods.

Authors:  D F Brown; D Kothari
Journal:  J Antimicrob Chemother       Date:  1978-01       Impact factor: 5.790

4.  Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review.

Authors:  M H Goldstein; R P Kowalski; Y J Gordon
Journal:  Ophthalmology       Date:  1999-07       Impact factor: 12.079

5.  Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones.

Authors:  G Alexandrakis; E C Alfonso; D Miller
Journal:  Ophthalmology       Date:  2000-08       Impact factor: 12.079

6.  Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates.

Authors:  Regis P Kowalski; Deepinder K Dhaliwal; Lisa M Karenchak; Eric G Romanowski; Francis S Mah; David C Ritterband; Y Jerold Gordon
Journal:  Am J Ophthalmol       Date:  2003-09       Impact factor: 5.258

7.  Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group.

Authors:  T P O'Brien; M G Maguire; N E Fink; E Alfonso; P McDonnell
Journal:  Arch Ophthalmol       Date:  1995-10

8.  Bacterial susceptibility to topical antimicrobials and clinical outcome in bacterial keratitis.

Authors:  Stephen Kaye; Stephen Tuft; Timothy Neal; Derek Tole; John Leeming; Francisco Figueiredo; Malcolm Armstrong; Peter McDonnell; Andrew Tullo; Christopher Parry
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-08-13       Impact factor: 4.799

9.  Topical 0.3% ciprofloxacin, norfloxacin, and ofloxacin in treatment of bacterial keratitis: a new method for comparative evaluation of ocular drug penetration.

Authors:  J P Diamond; L White; J P Leeming; H Bing Hoh; D L Easty
Journal:  Br J Ophthalmol       Date:  1995-06       Impact factor: 4.638

10.  Distribution of bacterial keratitis and emerging resistance to antibiotics in China from 2001 to 2004.

Authors:  Chen Zhang; Yanchuang Liang; Shijing Deng; Zhiqun Wang; Ran Li; Xuguang Sun
Journal:  Clin Ophthalmol       Date:  2008-09
View more
  24 in total

1.  Risk factors for contact lens-related microbial keratitis in Singapore.

Authors:  C H L Lim; N A Carnt; M Farook; J Lam; D T Tan; J S Mehta; F Stapleton
Journal:  Eye (Lond)       Date:  2015-12-04       Impact factor: 3.775

Review 2.  Antibiotic Resistance in the Treatment of Staphylococcus aureus Keratitis: a 20-Year Review.

Authors:  Victoria S Chang; Deepinder K Dhaliwal; Leela Raju; Regis P Kowalski
Journal:  Cornea       Date:  2015-06       Impact factor: 2.651

Review 3.  Pattern recognition receptors in microbial keratitis.

Authors:  M-A Taube; M del Mar Cendra; A Elsahn; M Christodoulides; P Hossain
Journal:  Eye (Lond)       Date:  2015-07-10       Impact factor: 3.775

4.  Twelve-year analysis of microbial keratitis trends at a UK tertiary hospital.

Authors:  S Z Tan; A Walkden; L Au; C Fullwood; A Hamilton; A Qamruddin; M Armstrong; A K Brahma; F Carley
Journal:  Eye (Lond)       Date:  2017-04-28       Impact factor: 3.775

5.  [Photodynamic therapy for infectious keratitis].

Authors:  N Szentmáry; S Goebels; M Bischoff; B Seitz
Journal:  Ophthalmologe       Date:  2012-02       Impact factor: 1.059

6.  Spectrum and resistance in bacterial infections of the ocular surface in a German tertiary referral center 2009-2019.

Authors:  Mathias Roth; Paul Goerke; Christoph Holtmann; Andreas Frings; Colin R MacKenzie; Gerd Geerling
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-06-10       Impact factor: 3.117

7.  Impact of the COVID-19 Pandemic on the Incidence and Characteristics of Culture-Positive Microbial Keratitis at a Tertiary Eye Hospital in the UK.

Authors:  Luke Michaels; Jay Richardson; Andrew Walkden; Fiona Carley
Journal:  Clin Ophthalmol       Date:  2022-08-10

8.  Bacterial Keratitis: Isolated Organisms and Antibiotic Resistance Patterns in San Francisco.

Authors:  Michelle Y Peng; Vicky Cevallos; Stephen D McLeod; Thomas M Lietman; Jennifer Rose-Nussbaumer
Journal:  Cornea       Date:  2018-01       Impact factor: 2.651

9.  Antibiotic therapies in maxillofacial surgery in the context of prophylaxis.

Authors:  Bogusława Orzechowska-Wylęgała; Adam Wylęgała; Michał Buliński; Iwona Niedzielska
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

10.  Management and treatment of contact lens-related Pseudomonas keratitis.

Authors:  Mark Dp Willcox
Journal:  Clin Ophthalmol       Date:  2012-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.